KALAMAZOO, Mich., Oct 30, 2009 /PRNewswire-FirstCall via COMTEX/ --
Stryker Corporation (NYSE: SYK) announced today that after a highly successful and distinguished 32-year career with Stryker Corporation, John W. Brown, has announced his decision to retire as Chairman of the Board and a Director effective December 31, 2009.
Mr. Brown joined the Company as President and Chief Executive Officer in 1977 and served in those positions until 2003. He has been a Director since 1977 and Chairman of the Board since 1981. Under Mr. Brown's leadership, Stryker has become one of the premier medical technology companies in the world.
In announcing his decision, Mr. Brown commented, "This timing is consistent with my original goal of providing a 5-year overlap with Steve MacMillan. The Company has done very well under Steve's leadership as CEO since January 2005, in spite of the challenges in today's economy and the current healthcare environment. We are also extremely fortunate to have a group of strong board members, many of whom have served the Company for a number of years. Additionally, three new members have joined the board during the last few years and are very experienced. This gives me great confidence that the Company is in good hands."
In recognition of Mr. Brown's tremendous contributions to the Company, the Board of Directors has appointed him Chairman Emeritus effective January 1, 2010. While he will no longer play an active role with the Company, Mr. Brown will be available for consultation to the Board.
The Company also announced that Stephen P. MacMillan, Stryker's President and CEO, has been appointed Chairman of the Board, in addition to his current responsibilities, effective January 1, 2010.
In announcing these changes, the Board of Directors commented that they were extremely grateful to Mr. Brown for his leadership and very pleased that he has agreed to serve as Chairman Emeritus. They also added that they were pleased that Mr. MacMillan has agreed to take on this additional responsibility and will look to him to ensure the Company's continued success.
Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. Stryker works with respected medical professionals to help people lead more active and more satisfying lives. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. For more information about Stryker, please visit www.stryker.com.
SOURCE Stryker Corporation
http://www.stryker.com
Read more...
Tags: career ceo communications contributions economy emergency environment healthcare medical nyse president products technology
Companies: Stryker Corp. (SYK)
Permalink
LITTLE ROCK, AR, Sep 11, 2009 (MARKETWIRE via COMTEX) --
Kelyniam Global, Inc. (PINKSHEETS: KLYG), an advanced Engineering
and Rapid Prototyping Company specializing in the use of CADCAM
technology, announces that Mr. Joseph Delligatti will be taking over
as Kelyniam's CEO, and Chairman of the Board of Directors.
Mr. Delligatti was the Director of Sales and Marketing for Stryker
Corporation's Physiotherapy Associates Division from September 2005
through July 2007. This Division was sold to a private equity firm in
June 2007. While at Stryker Corporation, a 6.7 Billion Dollar Medical
Supplier out of Kalamazoo, Michigan, Mr. Delligatti was the U.S.
Director of Sales from 1997-1998, National Accounts Manager from
1998-1999, Director of Healthcare Services from 1999-2001, Director
of New Business Development from 2001-2005, and Director of Sales and
Marketing from 2005-2007.
James Ketner, President and CEO of Kelyniam Global, Inc., stated:
"Kelyniam is now positioned to go in a completely different direction
than when I started the company back in 2005. It is time for the
management to reflect this new direction. As a fellow shareholder, I
realize that we are extremely fortunate to have been able to recruit
Mr. Delligatti to lead the company in this new direction of medical
devises."
Mr. Ketner will remain on the Board of Directors, and will also
assume the role of the President of the Engineering Division of
Kelyniam Global, Inc.
Mr. Delligatti has a Bachelors of Arts in Psychology and Business
from St. John's University, and has attended Harvard Business School
Management Program, Harvard Negotiation School Program, Gallup
Leadership Training Program, AMA Sales Management Training, SYSTEMA
and P.S.S. Sales Training.
Kelyniam Global, Inc. recently posted a video which tells more about
the company's new and exciting medical process utilizing CADCAM
technology. The video can be watched by going to the company website,
and selecting the "Watch our New Medical Video" on Kelyniam's home
page, or by following the link www.kelyniam.com/video.wmv.
About Kelyniam Global, Incorporated:
Kelyniam Global, Inc. specializes in the use of CADCAM technology
with recent developments in the production of high precision
replication of artificial bone implants for medical applications.
The company services a vast array of industries such as medical,
automotive, aerospace, jewelry, nautical and consumer products.
Please visit our website at www.kelyniam.com for more information.
Contact:
Kelyniam Investor Relations at:
Buzzbahn Media
6800 Jericho Turnpike
Jericho, NY
516-439-4178
SOURCE: Kelyniam Global, Inc.
Read more...
Tags: aerospace automotive business ceo consumer products dollar engineering healthcare marketing media medical michigan new_york president Private Equity psychology sales technology training university video
Companies: Kelyniam Global Inc (KLYG), Kelyniam Global Inc (KLYG), Stryker Corp. (SYK)
Permalink
